SAFETY OF HEPATITIS-B VACCINES CONTAINING INTACT 20 nm PARTICLES
- 1 March 1979
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 313 (8114) , 488
- https://doi.org/10.1016/s0140-6736(79)90836-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Detection of Antibodies Directed against a Liver-Specific Membrane Lipoprotein in Patients with Acute and Chronic Active HepatitisNew England Journal of Medicine, 1978
- Clinical Diagnosis of the Inborn Errors of Metabolism in the Neonatal PeriodPediatrics, 1978
- Liver-cell-membrane autoantibody specific for inflammatory liver diseases.BMJ, 1977
- Hepatitis B subunit vaccineThe Lancet Healthy Longevity, 1975
- Inhibition of Fc receptors on a murine lymphoid cell line by cholera exotoxinNature, 1975
- Test Paper for Galactose in UrineScandinavian Journal of Clinical and Laboratory Investigation, 1968
- SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSISThe Lancet, 1965
- The quantitative determination of galactose—An enzymic method using galactose oxidase, with applications to blood and other biological fluidsAnalytical Biochemistry, 1965